首页 > 最新文献

F1000 medicine reports最新文献

英文 中文
Advances in laryngoscopy: rigid indirect laryngoscopy. 喉镜检查的进展:刚性间接喉镜检查。
Pub Date : 2010-08-19 DOI: 10.3410/M2-61
Deanne R Cheyne, Patrick Doyle

There is a growing body of evidence to support the use of rigid indirect laryngoscopy or 'video' laryngoscopy for tracheal intubation. We summarise some of the key issues, comparing rigid indirect laryngoscopy with direct conventional laryngoscopy.

越来越多的证据支持使用刚性间接喉镜或“视频”喉镜进行气管插管。我们总结了一些关键问题,比较刚性间接喉镜与直接常规喉镜。
{"title":"Advances in laryngoscopy: rigid indirect laryngoscopy.","authors":"Deanne R Cheyne,&nbsp;Patrick Doyle","doi":"10.3410/M2-61","DOIUrl":"https://doi.org/10.3410/M2-61","url":null,"abstract":"<p><p>There is a growing body of evidence to support the use of rigid indirect laryngoscopy or 'video' laryngoscopy for tracheal intubation. We summarise some of the key issues, comparing rigid indirect laryngoscopy with direct conventional laryngoscopy.</p>","PeriodicalId":88480,"journal":{"name":"F1000 medicine reports","volume":"2 ","pages":"61"},"PeriodicalIF":0.0,"publicationDate":"2010-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/44/13/medrep-02-61.PMC2990653.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29548612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Recent advances in the treatment of pain. 疼痛治疗的最新进展。
Pub Date : 2010-08-19 DOI: 10.3410/M2-63
Mellar P Davis

Cancer pain and chronic non-malignant pain can be difficult to manage and may not respond satisfactorily to standard analgesics. Sequential empiric analgesic trials are usually done to manage individual patients. Experimental human pain models have helped to clarify mechanisms of opioid and adjuvant analgesic actions. Combinations of opioids and adjuvant analgesics better relieve pain than either opioids or adjuvant analgesics alone, as demonstrated in randomized controlled trials. The analgesic activity of antidepressants is largely dependent upon norepinephrine reuptake and activation of alpha 2 adrenergic receptors. Corticosteroids reduce postoperative orthopedic incident pain, which may allow patients to ambulate earlier and with less pain. Spinal corticosteroids reduce lower hemibody pain. Gabapentinoids as single high doses reduce postoperative pain and certain acute pain syndromes. Individuals who experience flares of pain while on spinal opioids benefit from intrathecal boluses of levobupivicaine or sublingual ketamine. Interventional approaches to pain management are often necessary due to the limitations of systemic analgesics. Electronics stimulators (peripheral, spinal and motor cortex) improve difficult to manage chronic pain syndromes. Pulsed radiofrequency reduces pain without tissue damage, which could be an advantage over chemical or radiofrequency neurotomy. Botulinum toxin A reduces focal neuropathic pain that is durable. Interventional related successes in relieving pain are operator dependent. Most reported benefits of systemic and regional analgesics and interventional approaches to pain relief are not based on randomized trials and are subject to selection bias, sampling error, and placebo responses, which may over-inflate reported benefits. Randomized controlled trials are needed to confirm reported benefits.

癌性疼痛和慢性非恶性疼痛可能难以控制,可能对标准止痛药反应不满意。序贯经验性镇痛试验通常用于管理个别患者。实验人类疼痛模型有助于阐明阿片类药物和辅助镇痛作用的机制。随机对照试验表明,阿片类药物和辅助镇痛药联合使用比单独使用阿片类药物或辅助镇痛药更能缓解疼痛。抗抑郁药的镇痛活性很大程度上依赖于去甲肾上腺素的再摄取和α 2肾上腺素能受体的激活。皮质类固醇可减少骨科术后疼痛,使患者能够更早地行走,减轻疼痛。脊髓皮质类固醇可减轻下半身疼痛。单次高剂量加巴喷丁类药物可减轻术后疼痛和某些急性疼痛综合征。服用脊髓阿片类药物时出现疼痛发作的个体可从鞘内注射左布比卡因或舌下氯胺酮中获益。由于全身镇痛药的局限性,介入治疗疼痛往往是必要的。电子刺激器(外周,脊髓和运动皮质)改善难以控制的慢性疼痛综合征。脉冲射频在不损伤组织的情况下减轻疼痛,这可能是化学或射频神经切开术的优势。肉毒毒素A减轻局灶性神经性疼痛,是持久的。缓解疼痛的介入相关成功取决于操作者。大多数报道的全身性和局部镇痛药以及介入镇痛方法的益处都不是基于随机试验,而且容易受到选择偏差、抽样误差和安慰剂反应的影响,这可能会夸大报道的益处。需要随机对照试验来证实报告的益处。
{"title":"Recent advances in the treatment of pain.","authors":"Mellar P Davis","doi":"10.3410/M2-63","DOIUrl":"https://doi.org/10.3410/M2-63","url":null,"abstract":"<p><p>Cancer pain and chronic non-malignant pain can be difficult to manage and may not respond satisfactorily to standard analgesics. Sequential empiric analgesic trials are usually done to manage individual patients. Experimental human pain models have helped to clarify mechanisms of opioid and adjuvant analgesic actions. Combinations of opioids and adjuvant analgesics better relieve pain than either opioids or adjuvant analgesics alone, as demonstrated in randomized controlled trials. The analgesic activity of antidepressants is largely dependent upon norepinephrine reuptake and activation of alpha 2 adrenergic receptors. Corticosteroids reduce postoperative orthopedic incident pain, which may allow patients to ambulate earlier and with less pain. Spinal corticosteroids reduce lower hemibody pain. Gabapentinoids as single high doses reduce postoperative pain and certain acute pain syndromes. Individuals who experience flares of pain while on spinal opioids benefit from intrathecal boluses of levobupivicaine or sublingual ketamine. Interventional approaches to pain management are often necessary due to the limitations of systemic analgesics. Electronics stimulators (peripheral, spinal and motor cortex) improve difficult to manage chronic pain syndromes. Pulsed radiofrequency reduces pain without tissue damage, which could be an advantage over chemical or radiofrequency neurotomy. Botulinum toxin A reduces focal neuropathic pain that is durable. Interventional related successes in relieving pain are operator dependent. Most reported benefits of systemic and regional analgesics and interventional approaches to pain relief are not based on randomized trials and are subject to selection bias, sampling error, and placebo responses, which may over-inflate reported benefits. Randomized controlled trials are needed to confirm reported benefits.</p>","PeriodicalId":88480,"journal":{"name":"F1000 medicine reports","volume":"2 ","pages":"63"},"PeriodicalIF":0.0,"publicationDate":"2010-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3410/M2-63","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29549321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
Differential diagnosis of thyroid nodules using fine-needle aspiration cytology and oncogene mutation screening: are we ready? 用细针穿刺细胞学和癌基因突变筛查鉴别诊断甲状腺结节:我们准备好了吗?
Pub Date : 2010-08-19 DOI: 10.3410/M2-62
Rosa Marina Melillo, Massimo Santoro, Giancarlo Vecchio

Thyroid nodules are a very common clinical finding, and although the majority of them are benign, thyroid carcinoma accounts for about 5-15% of nodules. Fine-needle aspiration cytology (FNAC) is actually used for the differential diagnosis of these lesions. Although in most cases this examination clearly distinguishes benign from malignant lesions, some fine-needle aspiration (FNA) samples fall into undetermined thyroid cytology categories, which according to the most recent classification of thyroid FNAC consist of 'suspicious for malignancy', 'suspicious for follicular or Hurtle cell neoplasm', and 'follicular lesion of undetermined significance/atypia of undetermined significance'. Moreover, some samples are insufficient for diagnosis. Taken together, these categories account for almost 20-30% of nodules. Owing to the high risk of papillary thyroid carcinoma, patients with lesions that are 'suspicious for malignancy' are currently subjected to lobectomy or total thyroidectomy. On the other hand, patients with 'atypia of undetermined significance' undergo repeated FNAs, and patients with 'suspicious for follicular or Hurtle cell neoplasm' are subjected to diagnostic lobectomy and subsequently, in the case of histological diagnosis of carcinoma, total thyroidectomy. Recent studies clearly indicate that molecular analysis of thyroid nodules can significantly improve the diagnostic power of cytology and drive the appropriate clinical management of these patients.

甲状腺结节是一种非常常见的临床表现,虽然大多数是良性的,但甲状腺癌约占结节的5-15%。细针穿刺细胞学(FNAC)实际上用于这些病变的鉴别诊断。虽然在大多数情况下,这种检查可以清楚地区分良性和恶性病变,但一些细针穿刺(FNA)样本属于不确定的甲状腺细胞学类别,根据甲状腺FNAC的最新分类,这些类别包括“可疑为恶性”、“可疑为滤泡或Hurtle细胞肿瘤”和“不确定意义的滤泡病变/不确定意义的异型性”。此外,一些样本不足以用于诊断。总的来说,这些类别占结节的近20-30%。由于甲状腺乳头状癌的高风险,目前对“疑似恶性”病变的患者进行肺叶切除术或全甲状腺切除术。另一方面,“意义不明的异型性”患者接受重复的FNAs,“疑似滤泡或Hurtle细胞肿瘤”的患者接受诊断性肺叶切除术,随后,在组织学诊断为癌的情况下,进行甲状腺全切除术。最近的研究清楚地表明,甲状腺结节的分子分析可以显著提高细胞学的诊断能力,并推动这些患者的适当临床管理。
{"title":"Differential diagnosis of thyroid nodules using fine-needle aspiration cytology and oncogene mutation screening: are we ready?","authors":"Rosa Marina Melillo,&nbsp;Massimo Santoro,&nbsp;Giancarlo Vecchio","doi":"10.3410/M2-62","DOIUrl":"https://doi.org/10.3410/M2-62","url":null,"abstract":"<p><p>Thyroid nodules are a very common clinical finding, and although the majority of them are benign, thyroid carcinoma accounts for about 5-15% of nodules. Fine-needle aspiration cytology (FNAC) is actually used for the differential diagnosis of these lesions. Although in most cases this examination clearly distinguishes benign from malignant lesions, some fine-needle aspiration (FNA) samples fall into undetermined thyroid cytology categories, which according to the most recent classification of thyroid FNAC consist of 'suspicious for malignancy', 'suspicious for follicular or Hurtle cell neoplasm', and 'follicular lesion of undetermined significance/atypia of undetermined significance'. Moreover, some samples are insufficient for diagnosis. Taken together, these categories account for almost 20-30% of nodules. Owing to the high risk of papillary thyroid carcinoma, patients with lesions that are 'suspicious for malignancy' are currently subjected to lobectomy or total thyroidectomy. On the other hand, patients with 'atypia of undetermined significance' undergo repeated FNAs, and patients with 'suspicious for follicular or Hurtle cell neoplasm' are subjected to diagnostic lobectomy and subsequently, in the case of histological diagnosis of carcinoma, total thyroidectomy. Recent studies clearly indicate that molecular analysis of thyroid nodules can significantly improve the diagnostic power of cytology and drive the appropriate clinical management of these patients.</p>","PeriodicalId":88480,"journal":{"name":"F1000 medicine reports","volume":"2 ","pages":"62"},"PeriodicalIF":0.0,"publicationDate":"2010-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ba/99/medrep-02-62.PMC2994260.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29545851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Relationships between mild traumatic brain injury sustained in combat and post-traumatic stress disorder. 战斗中轻度创伤性脑损伤与创伤后应激障碍之间的关系。
Pub Date : 2010-08-19 DOI: 10.3410/M2-64
Robert L Ruff, Ronald G Riechers, Suzanne S Ruff

The setting of the trauma is a distinguishing feature between mild traumatic brain injury (mTBI; also called concussion) that occurs in civilian settings compared with that occurring in combat. Combat mTBI is frequently associated with a prolonged stress reaction, post-traumatic stress disorder (PTSD). Individuals with mTBI and PTSD from combat in Operations Iraqi Freedom and Enduring Freedom often develop prolonged post-concussion symptoms (PCSs) such as headache. Both mTBI and PTSD may contribute to PCSs. PTSD may worsen and prolong the PCSs following mTBI by disrupting sleep. It is not known how mTBI predisposes an individual to develop PTSD.

创伤的环境是轻度创伤性脑损伤(mTBI;也称为脑震荡)发生在平民环境中,而不是发生在战斗中。战斗型mTBI通常与长期的应激反应,创伤后应激障碍(PTSD)有关。在伊拉克自由行动和持久自由行动中患有mTBI和创伤后应激障碍的个体通常会出现长期的脑震荡后症状(PCSs),如头痛。mTBI和PTSD都可能导致psss。创伤后应激障碍可使mTBI后的PCSs恶化并因睡眠中断而延长。目前尚不清楚mTBI是如何使个体易患PTSD的。
{"title":"Relationships between mild traumatic brain injury sustained in combat and post-traumatic stress disorder.","authors":"Robert L Ruff,&nbsp;Ronald G Riechers,&nbsp;Suzanne S Ruff","doi":"10.3410/M2-64","DOIUrl":"https://doi.org/10.3410/M2-64","url":null,"abstract":"<p><p>The setting of the trauma is a distinguishing feature between mild traumatic brain injury (mTBI; also called concussion) that occurs in civilian settings compared with that occurring in combat. Combat mTBI is frequently associated with a prolonged stress reaction, post-traumatic stress disorder (PTSD). Individuals with mTBI and PTSD from combat in Operations Iraqi Freedom and Enduring Freedom often develop prolonged post-concussion symptoms (PCSs) such as headache. Both mTBI and PTSD may contribute to PCSs. PTSD may worsen and prolong the PCSs following mTBI by disrupting sleep. It is not known how mTBI predisposes an individual to develop PTSD.</p>","PeriodicalId":88480,"journal":{"name":"F1000 medicine reports","volume":"2 ","pages":"64"},"PeriodicalIF":0.0,"publicationDate":"2010-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/59/a1/medrep-02-64.PMC2990449.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29549323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 26
New methods for diagnosis and treatment of vestibular diseases. 前庭疾病诊断与治疗的新方法。
Pub Date : 2010-08-09 DOI: 10.3410/M2-60
Stefan Ca Hegemann, Antonella Palla

Dizziness and vertigo are common complaints, with a lifetime prevalence of over 30%. This review provides a brief summary of the recent diagnostic and therapeutic advances in the field of neuro-otology. A special focus is placed on the clinical usefulness of vestibular tests. While these have markedly improved over the years, treatment options for vestibular disorders still remain limited. Available therapies for selected vestibular diseases are discussed.

头晕和眩晕是常见的主诉,终生患病率超过30%。本文综述了近年来神经耳科的诊断和治疗进展。一个特别的重点放在临床有用的前庭测试。虽然这些年来有了明显的改善,但前庭疾病的治疗选择仍然有限。对选定的前庭疾病的可用治疗方法进行了讨论。
{"title":"New methods for diagnosis and treatment of vestibular diseases.","authors":"Stefan Ca Hegemann,&nbsp;Antonella Palla","doi":"10.3410/M2-60","DOIUrl":"https://doi.org/10.3410/M2-60","url":null,"abstract":"<p><p>Dizziness and vertigo are common complaints, with a lifetime prevalence of over 30%. This review provides a brief summary of the recent diagnostic and therapeutic advances in the field of neuro-otology. A special focus is placed on the clinical usefulness of vestibular tests. While these have markedly improved over the years, treatment options for vestibular disorders still remain limited. Available therapies for selected vestibular diseases are discussed.</p>","PeriodicalId":88480,"journal":{"name":"F1000 medicine reports","volume":"2 ","pages":"60"},"PeriodicalIF":0.0,"publicationDate":"2010-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3410/M2-60","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29548610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
On diagnostic blocks for lumbar zygapophysial joint pain. 腰椎关节关节疼痛的诊断阻滞。
Pub Date : 2010-08-09 DOI: 10.3410/M2-57
Nikolai Bogduk

Diagnostic blocks are used to identify patients with back pain stemming from their lumbar zygapophysial joints. Single, diagnostic blocks have an unacceptably high false positive rate. As well, comparative local anaesthetic blocks lack validity because the prevalence of the condition is low. Relying on 50% relief following single-diagnostic blocks does not provide a valid diagnosis. Placebo-controlled blocks are the only available valid means of establishing a diagnosis of lumbar zygapophysial joint pain.

诊断块用于识别腰关节关节关节疼痛的患者。单个诊断块的假阳性率高得令人无法接受。同样,相对局部麻醉阻滞缺乏有效性,因为这种情况的患病率很低。依靠单一诊断块后50%的缓解并不能提供有效的诊断。安慰剂对照阻滞是唯一有效的诊断腰椎关节关节疼痛的方法。
{"title":"On diagnostic blocks for lumbar zygapophysial joint pain.","authors":"Nikolai Bogduk","doi":"10.3410/M2-57","DOIUrl":"https://doi.org/10.3410/M2-57","url":null,"abstract":"<p><p>Diagnostic blocks are used to identify patients with back pain stemming from their lumbar zygapophysial joints. Single, diagnostic blocks have an unacceptably high false positive rate. As well, comparative local anaesthetic blocks lack validity because the prevalence of the condition is low. Relying on 50% relief following single-diagnostic blocks does not provide a valid diagnosis. Placebo-controlled blocks are the only available valid means of establishing a diagnosis of lumbar zygapophysial joint pain.</p>","PeriodicalId":88480,"journal":{"name":"F1000 medicine reports","volume":"2 ","pages":"57"},"PeriodicalIF":0.0,"publicationDate":"2010-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/69/d8/medrep-02-57.PMC2990543.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29548604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 40
Recent advances in hormonal contraception. 激素避孕的最新进展。
Pub Date : 2010-08-09 DOI: 10.3410/M2-58
Hw Raymond Li, Richard A Anderson

This report reviews some of the new studies regarding new hormonal contraceptive formulations (e.g., Yaz, Qlaira(®), extended-cycle or continuous combined contraceptives, subcutaneous depot medroxyprogesterone acetate, and ulipristal acetate as an emergency contraceptive). Recent data on the relationship between hormonal contraceptive use and bone health are also reviewed.

本报告综述了一些关于新的激素避孕药配方的新研究(如Yaz、Qlaira(®)、延长周期或连续联合避孕药、皮下储存醋酸甲孕酮和醋酸乌普利司酮作为紧急避孕药)。最近的数据对激素避孕药的使用和骨骼健康之间的关系也进行了审查。
{"title":"Recent advances in hormonal contraception.","authors":"Hw Raymond Li,&nbsp;Richard A Anderson","doi":"10.3410/M2-58","DOIUrl":"https://doi.org/10.3410/M2-58","url":null,"abstract":"<p><p>This report reviews some of the new studies regarding new hormonal contraceptive formulations (e.g., Yaz, Qlaira(®), extended-cycle or continuous combined contraceptives, subcutaneous depot medroxyprogesterone acetate, and ulipristal acetate as an emergency contraceptive). Recent data on the relationship between hormonal contraceptive use and bone health are also reviewed.</p>","PeriodicalId":88480,"journal":{"name":"F1000 medicine reports","volume":"2 ","pages":"58"},"PeriodicalIF":0.0,"publicationDate":"2010-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3410/M2-58","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29548605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Is there evidence for a set point that regulates human body weight? 有证据表明存在一个调节人体体重的设定值吗?
Pub Date : 2010-08-09 DOI: 10.3410/M2-59
Manfred J Müller, Anja Bosy-Westphal, Steven B Heymsfield

There is evidence for the idea that there is biological (active) control of body weight at a given set point. Body weight is the product of genetic effects (DNA), epigenetic effects (heritable traits that do not involve changes in DNA), and the environment. Regulation of body weight is asymmetric, being more effective in response to weight loss than to weight gain. However, regulation may be lost or camouflaged by Western diets, suggesting that the failure of biological control is due mainly to external factors. In this situation, the body's 'set point' (i.e., a constant 'body-inherent' weight regulated by a proportional feedback control system) is replaced by various 'settling points' that are influenced by energy and macronutrient intake in order for the body to achieve a zero energy balance. In a world of abundance, a prudent lifestyle and thus cognitive control are preconditions of effective biological control and a stable body weight. This idea also impacts future genetic research on body weight regulation. Searching for the genetic background of excess weight gain in a world of abundance is misleading since the possible biological control is widely overshadowed by the effect of the environment. In regard to clinical practice, dietary approaches to both weight loss and weight gain have to be reconsidered. In underweight patients (e.g., patients with anorexia nervosa), weight gain is supported by biological mechanisms that may or may not be suppressed by hyperalimentation. To overcome weight loss-induced counter-regulation in the overweight, biological signals have to be taken into account. Computational modeling of weight changes based on metabolic flux and its regulation will provide future strategies for clinical nutrition.

有证据表明,在给定的设定值上,存在对体重的生物(主动)控制。体重是遗传效应(DNA)、表观遗传效应(不涉及DNA变化的可遗传性状)和环境的产物。体重的调节是不对称的,对体重减轻的反应比对体重增加的反应更有效。然而,调控可能被西方饮食所忽略或掩盖,这表明生物控制的失败主要是由于外部因素。在这种情况下,身体的“设定点”(即由比例反馈控制系统调节的恒定“身体固有”体重)被各种“稳定点”所取代,这些“稳定点”受能量和宏量营养素摄入量的影响,以使身体达到零能量平衡。在一个物质丰富的世界里,谨慎的生活方式和认知控制是有效的生物控制和稳定体重的先决条件。这一观点也影响了未来关于体重调节的基因研究。在一个物质丰富的世界里寻找体重增加的遗传背景是有误导性的,因为可能的生物控制被环境的影响所掩盖。就临床实践而言,减肥和增重的饮食方法都必须重新考虑。在体重过轻的患者(如神经性厌食症患者)中,体重增加是由生物机制支持的,这种机制可能被高营养抑制也可能不被高营养抑制。为了克服体重减轻引起的超重反调节,必须考虑到生物信号。基于代谢通量及其调控的体重变化计算模型将为临床营养提供未来的策略。
{"title":"Is there evidence for a set point that regulates human body weight?","authors":"Manfred J Müller,&nbsp;Anja Bosy-Westphal,&nbsp;Steven B Heymsfield","doi":"10.3410/M2-59","DOIUrl":"https://doi.org/10.3410/M2-59","url":null,"abstract":"<p><p>There is evidence for the idea that there is biological (active) control of body weight at a given set point. Body weight is the product of genetic effects (DNA), epigenetic effects (heritable traits that do not involve changes in DNA), and the environment. Regulation of body weight is asymmetric, being more effective in response to weight loss than to weight gain. However, regulation may be lost or camouflaged by Western diets, suggesting that the failure of biological control is due mainly to external factors. In this situation, the body's 'set point' (i.e., a constant 'body-inherent' weight regulated by a proportional feedback control system) is replaced by various 'settling points' that are influenced by energy and macronutrient intake in order for the body to achieve a zero energy balance. In a world of abundance, a prudent lifestyle and thus cognitive control are preconditions of effective biological control and a stable body weight. This idea also impacts future genetic research on body weight regulation. Searching for the genetic background of excess weight gain in a world of abundance is misleading since the possible biological control is widely overshadowed by the effect of the environment. In regard to clinical practice, dietary approaches to both weight loss and weight gain have to be reconsidered. In underweight patients (e.g., patients with anorexia nervosa), weight gain is supported by biological mechanisms that may or may not be suppressed by hyperalimentation. To overcome weight loss-induced counter-regulation in the overweight, biological signals have to be taken into account. Computational modeling of weight changes based on metabolic flux and its regulation will provide future strategies for clinical nutrition.</p>","PeriodicalId":88480,"journal":{"name":"F1000 medicine reports","volume":"2 ","pages":"59"},"PeriodicalIF":0.0,"publicationDate":"2010-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3410/M2-59","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29548607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 56
Management of acromegaly. 肢端肥大症的治疗。
Pub Date : 2010-07-22 DOI: 10.3410/M2-54
Vladimir Vasilev, Adrian Daly, Sabina Zacharieva, Albert Beckers

Acromegaly is caused by hypersecretion of growth hormone and resultant overproduction of insulin-like growth factor-1 and is associated with increased mortality and morbidity. Successful treatment modalities have been developed and are used in a multistep approach allowing normal life expectancy as well as improved quality of life in an increasing number of patients.

肢端肥大症是由生长激素分泌过多和由此产生的胰岛素样生长因子-1过量引起的,与死亡率和发病率增加有关。已经开发出成功的治疗方式,并在多步骤方法中使用,使越来越多的患者的预期寿命正常,并改善了生活质量。
{"title":"Management of acromegaly.","authors":"Vladimir Vasilev,&nbsp;Adrian Daly,&nbsp;Sabina Zacharieva,&nbsp;Albert Beckers","doi":"10.3410/M2-54","DOIUrl":"https://doi.org/10.3410/M2-54","url":null,"abstract":"<p><p>Acromegaly is caused by hypersecretion of growth hormone and resultant overproduction of insulin-like growth factor-1 and is associated with increased mortality and morbidity. Successful treatment modalities have been developed and are used in a multistep approach allowing normal life expectancy as well as improved quality of life in an increasing number of patients.</p>","PeriodicalId":88480,"journal":{"name":"F1000 medicine reports","volume":"2 ","pages":"54"},"PeriodicalIF":0.0,"publicationDate":"2010-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3410/M2-54","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29549327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Clinical applications of breath testing. 呼气测试的临床应用。
Pub Date : 2010-07-22 DOI: 10.3410/M2-56
Kelly M Paschke, Alquam Mashir, Raed A Dweik

Breath testing has the potential to benefit the medical field as a cost-effective, non-invasive diagnostic tool for diseases of the lung and beyond. With growing evidence of clinical worth, standardization of methods, and new sensor and detection technologies the stage is set for breath testing to gain considerable attention and wider application in upcoming years.

呼气测试作为一种成本效益高、非侵入性的肺部疾病诊断工具,有可能使医疗领域受益。随着临床价值的证据越来越多,方法的标准化,以及新的传感器和检测技术,呼吸测试将在未来几年获得相当的关注和更广泛的应用。
{"title":"Clinical applications of breath testing.","authors":"Kelly M Paschke,&nbsp;Alquam Mashir,&nbsp;Raed A Dweik","doi":"10.3410/M2-56","DOIUrl":"https://doi.org/10.3410/M2-56","url":null,"abstract":"<p><p>Breath testing has the potential to benefit the medical field as a cost-effective, non-invasive diagnostic tool for diseases of the lung and beyond. With growing evidence of clinical worth, standardization of methods, and new sensor and detection technologies the stage is set for breath testing to gain considerable attention and wider application in upcoming years.</p>","PeriodicalId":88480,"journal":{"name":"F1000 medicine reports","volume":"2 ","pages":"56"},"PeriodicalIF":0.0,"publicationDate":"2010-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3410/M2-56","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29549778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 52
期刊
F1000 medicine reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1